arrow_back Trending Legislation
Share share

Faster Approval for Emergency Drugs and Medical Devices.

New rules allow data from emergencies (e.g., pandemics) to be used for faster approval of drugs, biological products, and medical devices. This means products proven effective in a crisis can reach the market for general use more quickly, potentially speeding up access to vital therapies and diagnostic tools for citizens.
Key points
Data gathered during emergencies (e.g., emergency use authorizations) can support applications for permanent approval of drugs and medical devices.
This facilitates quicker market entry for products already demonstrated as effective and safe in crisis situations.
It does not alter safety standards or approval requirements, only allows the use of existing, reliable data.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
A bill to provide for the use of emergency use authorization data and real world evidence gathered during an emergency to support premarket applications for drugs, biological products, and devices, and for other purposes.
Print number: S 1508
Sponsor: Sen. Marshall, Roger [R-KS]
Process start date: 2021-04-29
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Faster Approval for Emergency Drugs and Medical Devices.

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 1508.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-04-29.

What are the main provisions?

Key points include:

  • Data gathered during emergencies (e.g., emergency use authorizations) can support applications for permanent approval of drugs and medical devices.
  • This facilitates quicker market entry for products already demonstrated as effective and safe in crisis situations.
  • It does not alter safety standards or approval requirements, only allows the use of existing, reliable data.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Marshall, Roger [R-KS].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

Analysis and Potential Impact of S 1508

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health